The most trusted news from Massachusetts

Provided by AGP

Got News to Share?

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on April 21, 2026

Ekaru Awarded GTIA Cybersecurity Trustmark for Excellence in Cybersecurity Practices
Aptia Earns Gold in the 2026 Hermes Creative Awards for Event Marketing Campaign at HR Tech
Uplizd, Inc. Launches Unified Infrastructure for Enterprise-Grade Agentic AI
The New England Center for Children Celebrates Susan Langer as Boston Red Sox ‘Most Valuable Educator’ Honoree
BookBud.ai Relaunches with Enhanced AI Book Creation and Integrated Global Distribution
AuthorVoices.ai Relaunches with AI Mastering Engine That Delivers Pro Quality Audiobooks in Under an Hour
SelfPublishing.pro Relaunches with AI-Powered Tools for Authors to Create, Publish, and Market Books
AI Book Editing Surpasses Most Professional Editors, New Service Demonstrates Breakthrough
AI-Powered Platform Generates Fully Custom Children's Books From Uploaded Photos in Minutes
AI Book Trailer Platform Cuts Production Time from Weeks to Minutes at Fraction of Traditional Cost
WalkPunch Launches AI-Powered Punch List Tool That Converts Job-Site Videos Into Trade-Sorted Action Items
SBA-Financed Internal Ownership Transitions Gain Momentum Among Engineering Firms Nationwide
National Shattering Silence Coalition Calls for Urgent Reform After Preventable Psychiatric System Failure in Alabama
Tropigas Modernizes Mission-Critical Energy Operations with Creatio
Liberty Defense Announces Pricing of its U.S. Initial Public Offering
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Aspen Aerogels Provides East Providence Facility Update
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

Share us

on your social networks:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.